Cointime

OncoMed Pharmaceuticals

company

About

OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.

  • 51 - 100

Highlights

Total Funding Amount
$154M
Funding Rounds
1
Investors
1
Investments
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$154M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Aug 1, 2004
Number Of Employee
51 - 100
Operating Status
Active

OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as “cancer stem cells”. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$154M
OncoMed Pharmaceuticals has raised a total of $154M in funding over 2 rounds. Their latest funding was raised on Nov 4, 2008 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 4, 2008 Series B $154M 1 Phase4 Ventures — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
OncoMed Pharmaceuticals has made 1 investments. Their most recent investment was on Mar 22, 2010, when ERPLY raised $2M.
Date Company Name
Round Money Raised Industry Lead Investor
Mar 22, 2010 ERPLY
Seed $2M Enterprise Resource Planning (ERP) —

Investors

Number of Lead Investors
Number of Investors
1
1
OncoMed Pharmaceuticals is funded by 1 investors. Phase4 Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Phase4 Ventures Yes Series B
Cointime
Content
Company